CNS Pharmaceuticals, Inc. reports

Company location: Houston, TX
Fiscal year end: 31 December

CNS Pharmaceuticals, Inc. has filed 379 SEC EDGAR filings since 13 Mar 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-20 of 20 matching filings.

Per page

Current page

10-Q File 001-39126

FORM 10-Q FOR MAR 2026

Filing date: 14 May 2026
Reporting date: 31 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR SEP 2025

Filing date: 14 Nov 2025
Reporting date: 30 Sep 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR JUN 2025

Filing date: 14 Aug 2025
Reporting date: 30 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR MAR 2025

Filing date: 15 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR SEPT 2024

Filing date: 14 Nov 2024
Reporting date: 30 Sep 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR JUNE 2024

Filing date: 14 Aug 2024
Reporting date: 30 Jun 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR 3/31/24

Filing date: 15 May 2024
Reporting date: 31 Mar 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

QUARTERLY REPORT

Filing date: 14 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

QUARTERLY REPORT

Filing date: 14 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

QUARTERLY REPORT

Filing date: 15 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 10 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 12 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 13 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 12 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q FOR JUNE 30, 2021

Filing date: 13 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 13 May 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 12 Nov 2020
Reporting date: 30 Sep 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

QUARTERLY REPORT

Filing date: 10 Aug 2020
Reporting date: 30 Jun 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 15 May 2020
Reporting date: 31 Mar 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39126

FORM 10-Q

Filing date: 20 Dec 2019
Reporting date: 30 Sep 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing